Safety evaluation and toxicology studies and related services for drug development

Active Awarded Last action

Contract number
75N95024D00020
Awardee
Awarding agency
Task orders
1 $547,006 obligated

Award facts

Opportunity
Combined order value
$547,006 Current and potential, with all options
Last date to order 39% complete
IDV ceiling 1% used
$48,622,546.00
Maximum order
$48,622,546.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030.

The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and IND-directed toxicology studies for small molecule and biologic drug candidates to support regulatory filings with the FDA, such as IND, NDA, and BLA applications. This includes activities like mitochondrial toxicity assays, in vivo dosing studies, and reproductive toxicology evaluations. IITRI has extensive experience conducting preclinical drug development services for federal agencies across multiple therapeutic areas. The contract is awarded under full and open competition without set-asides.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95024D00020?

75N95024D00020 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on June 20, 2024.

How much is contract 75N95024D00020 worth?

Orders under 75N95024D00020 have obligated $547,006. 75N95024D00020's own ceiling is $48,622,546. A single order can be worth up to $48,622,546.

How many orders have been placed under contract 75N95024D00020?

1 order has been placed under 75N95024D00020, the latest on September 18, 2024.

Which agency awarded contract 75N95024D00020?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024D00020, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract 75N95024D00020?

75N95024D00020 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95024D00020 part of a contract vehicle?

Yes. 75N95024D00020 is part of Safety Evaluation and Toxicology Studies and Related Services for Drug Development.

Was contract 75N95024D00020 competed?

The extent of competition for 75N95024D00020 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV